News Havas Lynx launches trial recruitment agency Havas Lynx Faze The Havas Lynx Group has launched Havas Lynx Faze, a specialist clinical trial recruitment agency that will be led by Mark Evans.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.